JP2006523185A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006523185A5 JP2006523185A5 JP2006503571A JP2006503571A JP2006523185A5 JP 2006523185 A5 JP2006523185 A5 JP 2006523185A5 JP 2006503571 A JP2006503571 A JP 2006503571A JP 2006503571 A JP2006503571 A JP 2006503571A JP 2006523185 A5 JP2006523185 A5 JP 2006523185A5
- Authority
- JP
- Japan
- Prior art keywords
- hybrid antigen
- tumor
- medicament
- heat shock
- shock protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44714203P | 2003-02-13 | 2003-02-13 | |
| US46246903P | 2003-04-11 | 2003-04-11 | |
| US46374603P | 2003-04-18 | 2003-04-18 | |
| US50341703P | 2003-09-16 | 2003-09-16 | |
| US10/776,521 US7420037B2 (en) | 2003-02-13 | 2004-02-12 | Heat shock protein-based vaccines and immunotherapies |
| PCT/US2004/004340 WO2004071457A2 (en) | 2003-02-13 | 2004-02-13 | Improved heat shock protein-based vaccines and immunotherapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006523185A JP2006523185A (ja) | 2006-10-12 |
| JP2006523185A5 true JP2006523185A5 (enExample) | 2007-05-10 |
Family
ID=32873068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006503571A Pending JP2006523185A (ja) | 2003-02-13 | 2004-02-13 | 改良された熱ショックタンパク質に基づくワクチンおよび免疫療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7420037B2 (enExample) |
| EP (1) | EP1622563A4 (enExample) |
| JP (1) | JP2006523185A (enExample) |
| AU (1) | AU2004212003B2 (enExample) |
| CA (1) | CA2520591A1 (enExample) |
| WO (1) | WO2004071457A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6761892B1 (en) * | 1995-08-18 | 2004-07-13 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
| US7309491B2 (en) * | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
| WO2004091493A2 (en) * | 2003-04-11 | 2004-10-28 | Antigenics, Inc. | Improved heat shock protein-based vaccines and immunotherapies |
| US7485312B2 (en) * | 2003-06-20 | 2009-02-03 | Dade Behring Marburg Gmbh | Surface protein (HBsAg) variant of the hepatitis B virus |
| AU2004274430A1 (en) * | 2003-09-12 | 2005-03-31 | Antigenics, Inc. | Vaccine for treatment and prevention of herpes simplex virus infection |
| WO2005067980A2 (en) * | 2004-01-12 | 2005-07-28 | Pointilliste, Inc. | Design of therapeutics and therapeutics |
| AU2006236294A1 (en) | 2005-04-19 | 2006-10-26 | Eli Lilly And Company | Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |
| EP2632939A4 (en) * | 2010-10-25 | 2014-05-14 | Academia Sinica Taiwan | CANCER-TREATED PEPTIDES AND THEIR USE IN CANCER TREATMENT AND DIAGNOSIS |
| EP2734231A1 (en) * | 2011-07-21 | 2014-05-28 | Biotech Tools S.A. | Dosage of dnak |
| EP3294324A1 (en) * | 2015-05-13 | 2018-03-21 | Agenus Inc. | Vaccines for treatment and prevention of cancer |
| WO2018187515A1 (en) | 2017-04-04 | 2018-10-11 | Avidea Technologies, Inc. | Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response |
| US11065317B2 (en) | 2018-04-26 | 2021-07-20 | Agenus Inc. | Heat shock protein-binding peptide compositions and methods of use thereof |
| AU2020315917A1 (en) * | 2019-07-24 | 2022-02-17 | Agenus Inc. | Antigenic polypeptides and methods of use thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8727030D0 (en) | 1987-11-18 | 1987-12-23 | Imp Cancer Res Tech | Production of monoclonal antibodies |
| US5498538A (en) | 1990-02-15 | 1996-03-12 | The University Of North Carolina At Chapel Hill | Totally synthetic affinity reagents |
| US5348945A (en) | 1990-04-06 | 1994-09-20 | Wake Forest University | Method of treatment with hsp70 |
| IL99821A (en) | 1991-10-22 | 1996-07-23 | Yeda Res & Dev | Antitumor vaccines comprising cells transfected with a gene encoding human il-6 |
| GB9202219D0 (en) * | 1992-02-03 | 1992-03-18 | Connaught Lab | A synthetic heamophilus influenzae conjugate vaccine |
| IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| GB9223816D0 (en) | 1992-11-13 | 1993-01-06 | Medical Res Council | Heat shock proteins and the treatment of tumours |
| PT700445E (pt) | 1993-06-04 | 2002-07-31 | Whitehead Biomedical Inst | Proteinas de stress e suas utilizacoes |
| US5750119A (en) | 1994-01-13 | 1998-05-12 | Mount Sinai School Of Medicine Of The City University Of New York | Immunotherapeutic stress protein-peptide complexes against cancer |
| US5997873A (en) | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
| US5961979A (en) | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| US5541109A (en) | 1994-04-19 | 1996-07-30 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Expression cloning of c-src SH3-domain binding proteins |
| WO1997006821A1 (en) * | 1995-08-18 | 1997-02-27 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
| AU727673B2 (en) | 1995-09-13 | 2000-12-21 | Fordham University | Therapeutic and prophylactic methods using heat shock proteins |
| US5837251A (en) | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
| US5985270A (en) | 1995-09-13 | 1999-11-16 | Fordham University | Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes |
| US5935576A (en) | 1995-09-13 | 1999-08-10 | Fordham University | Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens |
| US6127393A (en) | 1995-12-29 | 2000-10-03 | Novactyl, Inc. | Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method |
| WO1997026910A2 (de) | 1996-01-27 | 1997-07-31 | Max-Delbrück-Centrum für Molekulare Medizin | Tumorimpfstoff für die immuntherapie von malignen tumoren |
| AU736318B2 (en) | 1996-11-26 | 2001-07-26 | Nventa Biopharmaceuticals Corporation | Immune responses using compositions containing stress proteins |
| US6017540A (en) | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| WO1998035705A1 (en) | 1997-02-18 | 1998-08-20 | Whitehead Institute For Biomedical Research | Use of heat shock proteins to deliver moieties into cells |
| US5962262A (en) | 1997-07-25 | 1999-10-05 | Incyte Pharmaceuticals, Inc. | Human heat shock 27 like protein |
| EP1027070A4 (en) * | 1997-10-31 | 2004-08-18 | Sloan Kettering Institutefor C | CONJUGATES FROM HEAT SHOCK PROTEIN-BINDING PEPTIDES |
| ES2439014T3 (es) | 1998-02-20 | 2014-01-21 | The University Of Miami | Complejo de péptido antigénico-proteína de choque térmico modificada |
| US6258782B1 (en) * | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| HUP0302681A3 (en) | 2000-04-17 | 2006-11-28 | Hoe Mee Irvington | Javelinization of protein antigens to heat shock proteins |
| US20040043419A1 (en) | 2001-04-17 | 2004-03-04 | Rothman James E. | Javelinization of protein antigens to heat shock proteins |
| US20040071656A1 (en) | 2001-12-26 | 2004-04-15 | Felix Wieland | Modulation of heat-shock-protein-based immunotherapies |
| US7309491B2 (en) | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
-
2004
- 2004-02-12 US US10/776,521 patent/US7420037B2/en not_active Expired - Lifetime
- 2004-02-13 EP EP04711217A patent/EP1622563A4/en not_active Withdrawn
- 2004-02-13 WO PCT/US2004/004340 patent/WO2004071457A2/en not_active Ceased
- 2004-02-13 JP JP2006503571A patent/JP2006523185A/ja active Pending
- 2004-02-13 CA CA002520591A patent/CA2520591A1/en not_active Abandoned
- 2004-02-13 AU AU2004212003A patent/AU2004212003B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006523185A5 (enExample) | ||
| ES2676630T3 (es) | Control inmunogénico de tumores y células tumorales | |
| JP2012511322A5 (enExample) | ||
| JP2010516290A5 (enExample) | ||
| JP2008535800A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| CN104918637A (zh) | 用作诱发抗原特异性t细胞反应的免疫原性增强剂的融合蛋白 | |
| FI2970398T3 (fi) | Rsv f -prefuusioproteiineja ja niiden käyttö | |
| JP2011521662A5 (enExample) | ||
| TWI455721B (zh) | 癌疫苗組合物 | |
| JP2018509935A5 (enExample) | ||
| JP2008530245A5 (enExample) | ||
| JP2012500006A5 (enExample) | ||
| HRP20190799T1 (hr) | Imunocitokini na bazi il-15 i sushi domene il-15r alfa | |
| JP2010500399A5 (enExample) | ||
| JP2012526839A5 (enExample) | ||
| WO2003090686A3 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| JP2009515831A5 (enExample) | ||
| AU2015204503A1 (en) | Novel vaccines against HPV and HPV-related diseases | |
| JP2016502515A5 (enExample) | ||
| CN111565746A (zh) | 用于预防和治疗多种黄病毒的mhc i类相关肽 | |
| JP2009520758A5 (enExample) | ||
| JP2019531293A5 (enExample) | ||
| JP2015533376A5 (enExample) | ||
| JP2012504602A5 (enExample) |